Lack of Association Between Variants within the AHSG, HCRT and NPY2R Genes and Anthropometrical Parameters in Czech Post-Monica Study

1. Lavebratt C, Alpman A, Persson B, Arner P, Hoffstedt J. Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men. Int J Obes. 2006; 30(3): 453-459.10.1038/sj.ijo.080318816331299Search in Google Scholar

2. Suchanek P, Kralova-Lesna I, Pledne R, Lanska V, Hubacek JA. An AHSG gene variant modulates baal metabolic rate and body composition development after a short-time lifestyle intervention. Neuroendocrinol Lett. 2011; 32(suppl 2): 32-36.Search in Google Scholar

3. Dahlman I, Eriksson P, Kaaman M, Jiao H, Lindgren CM, Kere J, et al. a2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia. 2004; 47(11): 1974-1979.10.1007/s00125-004-1556-715599699Search in Google Scholar

4. Siddiq A, Lepretre F, Hercberg S, Froguel P, Gibson F. A synonymous coding polymorphism in the a2-Here-mans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes. 2005; 54(8): 2477-2481.10.2337/diabetes.54.8.247716046317Search in Google Scholar

5. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, et al. a2-Heremans-Schmid glyco-protein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006; 29(4): 853-857.10.2337/diacare.29.04.06.dc05-193816567827Search in Google Scholar

6. Fisher E, Stefan N, Saar K, Drogan D, Schulze MB, Fritsche A, et al. Association of AHSG gene polymor-phisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2009; 2(6): 607-613.10.1161/CIRCGENETICS.109.87041020031641Search in Google Scholar

7. Muendlein A, Stark N, Rein P, Saely CH, Geller- Rhomberg S, Geiger K, et al. Are AHSG polymorphisms directly associated with coronary atherosclerosis? Clin Chim Acta. 2012; 413(1-2): 287-290.10.1016/j.cca.2011.10.00822024217Search in Google Scholar

8. Andersen G, Burgdorf KS, Sparsø T, Borch- Johnsen K, Jørgensen T, Hansen T, et al. AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects. Diabetes. 2008; 57(5): 1427-1432.10.2337/db07-055818316360Search in Google Scholar

9. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the AHSG gene. Diabetes. 2002; 51(8): 2450-2458.10.2337/diabetes.51.8.245012145157Search in Google Scholar

10. Ganjavi H, Shapiro CM. Hypocretin/Orexin: a molecular link between sleep, energy regulation, and pleasure. J Neuropsychiatry Clin Neurosci. 2007; 19(4): 413-419.10.1176/jnp.2007.19.4.41318070844Search in Google Scholar

11. Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, et al. Structure and function of human prepro-orexin gene. J Biol Chem. 1999; 274(25): 17771-17776.10.1074/jbc.274.25.1777110364220Search in Google Scholar

12. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus- specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998; 95(1): 322-327.10.1073/pnas.95.1.322Search in Google Scholar

13. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998; 92(4): 573-585.10.1016/S0092-8674(00)80949-6Search in Google Scholar

14. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, et al. Genetic ablarton of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuwron. 2001; 30(2): 345-354.Search in Google Scholar

15. Bronsky J, Nedvidkova J, Zamrazilova H, Pechova M, Chada M, Kotaska K, et al. Dynamic changes of orexin A and leptin in obese children during body weight reduction. Physiol Res. 2007; 56(1): 89-96.10.33549/physiolres.93086016497092Search in Google Scholar

16. Adam JA, Menheere PPCA, Van Dielen FMH, Soeters PB, Buurman WA, Greve JWM. Decreased plasma orexin-A levels in obese individuals. Int J Obes Relat Metab Disord. 2002; 26(2): 274-276.10.1038/sj.ijo.080186811850761Search in Google Scholar

17. Kok SW, Meinders AE, Overeem S, Lammers GJ, Roelfsema F, Frölich M, et al. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab. 2002; 87(2): 805-809.10.1210/jcem.87.2.824611836325Search in Google Scholar

18. Hungs M, Lin L, Okun M, Mignot E. Polymorphisms in the vicinity of the hypocretin/orexin are not associated with human narcolepsy. Neurology. 2001; 57 (10): 1893-1895.10.1212/WNL.57.10.189311723284Search in Google Scholar

19. Ammar DA, Eadie DM, Wong DJ, Ma Y-Y, Kolakowski LF Jr, Yang-Feng TL, et al. Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene. Genomics. 1996; 38(3): 392 398.10.1006/geno.1996.06428975716Search in Google Scholar

20. Chen C-H, Stephens RL Jr, Rogers RC. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol Mot. 1997; 9(2): 109-116.10.1046/j.1365-2982.1997.d01-26.x9198086Search in Google Scholar

21. Siddiq A, Gueorguiev M, Samson C, Hercberg S, Heude B, Levy-Marchal C, et al. Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects. Diabetologia. 2007; 50(3): 574-584.10.1007/s00125-006-0555-217235527Search in Google Scholar

22. Hunt SC, Hasstedt SJ, Xin Y, Dalley BK, Malish BA, Yakobson E, et al. Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects. Obesity. 2011; 19(11): 2241-2247.10.1038/oby.2011.239373317321818152Search in Google Scholar

23. Hung Ch-ChC, Pirie F, Luan J, Lank E, Motala A, Yeo GSH, et al. Studies of the peptide YY and neuropep-tide Y2 receptor genes in relation to human obesity and obesity-related traits. Diabetes. 2004; 53(9): 2461-2466.10.2337/diabetes.53.9.246115331560Search in Google Scholar

24. Tunstall-Pedoe H. MONICA’s quarter century. Eur J Cardiovasc Prev Rehabil. 2003; 10(6): 409-410.10.1097/01.hjr.0000102816.74402.1214671462Search in Google Scholar

25. Thunsdall-Pedoe H, Kuulasmaa K, Tolonen H, Davidson M, Mendis S. MONICA monograph and multimedia sourcebook. Thunsdall-Pedoe H, Ed. Geneva: World Health Organization, 2003.Search in Google Scholar

26. Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H, et al. Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb. 2010; 17(9): 925-933.10.5551/jat.383020543523Search in Google Scholar

27. Singh M, Sharma PK, Garg VK, Mondal SC, Singh AK, Kumar N. Role of fetuin-A in atherosclerosis associated with diabetic patients. J Pharm Pharmacol. 2012; 64(12): 1703-1708. 10.1111/j.2042-7158.2012.01561.x23146032Search in Google Scholar